| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b55c349b43c3ecba4977fd52cc8f8c67 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3521
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3533
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-322 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y205-01018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 |
| filingDate |
2016-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b67d3f0aa772ff6e0dd430dfd1dd348
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f165e7ff5ba277d9e40c7bae6d5eedf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf7a7a4b51fec78b6babf72d894f8bd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e13b2a5177529676f6b99dcde5cee27a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1170991b2a03a1b7d8947b1e3cdf271
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65c048fec1e5c535f3ce5d491562ddda |
| publicationDate |
2018-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-108367022-A |
| titleOfInvention |
With high activity and reduce the SIRNA structures missed the target |
| abstract |
The present invention is provided to use RNA to interfere to adjust compound, composition and the method for expression of target gene.The RNAi structures and molecule of the present invention can be used for being adjusted gene expression with high-caliber RNAi activity and the effect of missing the target reduced or being made silenced gene expression.SiRNA that advantageous structure includes the arbitrary gene of targeting, containing one or more 2 ' deoxynucleotides in seed zone.The rnai molecule can be used for preventing or treat in the method for disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022028462-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110714025-A |
| priorityDate |
2015-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |